CD4 and cancer: In effector cells harvested from ascites of patients suffering from EpCAM-positive cancers, the bAb has further been shown to induce effector cytokines such as interferon-γ and upregulation of surface-expressed CD107a indicative of cytotoxic granule release in both CD4+ and CD8+ T cells [29].